Zurich Cantonal Bank
LRMR icon

Zurich Cantonal Bank’s Larimar Therapeutics LRMR Stock Holding History

Zurich Cantonal Bank’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,395
Closed -$26K – 2790
2021
Q4 		$26K Sell
2,395
-249
-9% -$2.77K ﹤0.01% 2839
2021
Q3 		$30K Buy
2,644
+9
+0.3% +$108 ﹤0.01% 2740
2021
Q2 		$26K Buy
2,635
+273
+12% +$3.08K ﹤0.01% 2560
2021
Q1 		$35K Buy
+2,362
New +$42.9K ﹤0.01% 2479

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return